Literature DB >> 8712382

A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients.

J A Wahr1, A Trouwborst, R K Spence, C P Henny, A C Cernaianu, G P Graziano, K K Tremper, K E Flaim, P E Keipert, N S Faithfull, J J Clymer.   

Abstract

A pilot study of a perfluorochemical (PFC) emulsion was undertaken to determine whether administration of a perflubron emulsion could result in measurable changes in mixed venous oxygen tension. Seven adult surgical patients received a 0.9-g PFC/kg intravenous dose of perflubron emulsion after acute normovolemic hemodilution (ANH). Hemodynamic and oxygen transport data were collected before and after ANH, immediately after PFC infusion, and at approximate 15-min intervals throughout the surgical period. There were no clinically significant hemodynamic changes associated with the administration of the PFC emulsion. There was a significant increase in mixed venous oxygen tension (PVO2) after the PFC infusion, while cardiac output and oxygen consumption were unchanged. As surgery progressed, the hemoglobin concentration decreased with ongoing blood loss while PVO2 values remained at or above predosing levels. Peak perflubron blood levels were 0.8 g/dL immediately postinfusion, and approximately 0.3 g/dL at 1 h. This pilot study demonstrates that administration of perflubron emulsion results in measurable changes in mixed venous oxygen tension during intraoperative ANH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712382     DOI: 10.1097/00000539-199601000-00018

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

Review 1.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

2.  Blood component therapy: Which, when and how much.

Authors:  Rajesh Chand Arya; Gs Wander; Pankaj Gupta
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04

Review 3.  Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions.

Authors:  D R Spahn
Journal:  Crit Care       Date:  1999-09-24       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.